Barclays PLC lowered its holdings in shares of Xylem Inc. (NYSE:XYL – Free Report) by 8.7% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 668,120 shares of the industrial products company’s stock after selling 63,458 shares during the period. Barclays PLC owned about 0.27% of Xylem worth $98,548,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also recently bought and sold shares of the business. Orion Porfolio Solutions LLC increased its stake in Xylem by 1.0% in the third quarter. Orion Porfolio Solutions LLC now owns 7,802 shares of the industrial products company’s stock valued at $1,151,000 after acquiring an additional 74 shares during the period. IFG Advisory LLC lifted its stake in Xylem by 9.3% during the third quarter. IFG Advisory LLC now owns 26,301 shares of the industrial products company’s stock worth $3,880,000 after purchasing an additional 2,237 shares during the period. Cambria Investment Management L.P. boosted its holdings in Xylem by 1.5% during the third quarter. Cambria Investment Management L.P. now owns 10,066 shares of the industrial products company’s stock valued at $1,485,000 after purchasing an additional 150 shares in the last quarter. Dimensional Fund Advisors LP boosted its holdings in Xylem by 9.2% during the third quarter. Dimensional Fund Advisors LP now owns 2,019,807 shares of the industrial products company’s stock valued at $297,857,000 after purchasing an additional 169,688 shares in the last quarter. Finally, Laffer Tengler Investments Inc. grew its stake in shares of Xylem by 14.5% in the 3rd quarter. Laffer Tengler Investments Inc. now owns 22,943 shares of the industrial products company’s stock valued at $3,384,000 after purchasing an additional 2,909 shares during the period. Institutional investors own 87.96% of the company’s stock.
Xylem Stock Down 2.4%
Shares of NYSE:XYL opened at $123.16 on Monday. The company has a quick ratio of 1.28, a current ratio of 1.62 and a debt-to-equity ratio of 0.12. The firm has a market cap of $29.95 billion, a P/E ratio of 31.42, a P/E/G ratio of 1.76 and a beta of 1.17. Xylem Inc. has a 12 month low of $100.47 and a 12 month high of $154.27. The company’s 50-day moving average price is $135.51 and its two-hundred day moving average price is $140.59.
Xylem declared that its Board of Directors has initiated a share repurchase plan on Wednesday, February 25th that allows the company to repurchase $1.50 billion in outstanding shares. This repurchase authorization allows the industrial products company to purchase up to 4.8% of its shares through open market purchases. Shares repurchase plans are usually an indication that the company’s board believes its shares are undervalued.
Xylem Increases Dividend
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, March 24th. Shareholders of record on Tuesday, February 24th will be given a dividend of $0.43 per share. This represents a $1.72 dividend on an annualized basis and a yield of 1.4%. The ex-dividend date is Tuesday, February 24th. This is a boost from Xylem’s previous quarterly dividend of $0.40. Xylem’s dividend payout ratio is currently 43.88%.
Analysts Set New Price Targets
A number of brokerages have weighed in on XYL. Oppenheimer set a $165.00 price target on Xylem in a research report on Thursday, February 12th. Royal Bank Of Canada cut their price objective on Xylem from $176.00 to $162.00 and set an “outperform” rating for the company in a report on Wednesday, February 11th. UBS Group restated a “buy” rating and issued a $155.00 target price on shares of Xylem in a research note on Friday, February 13th. Weiss Ratings reaffirmed a “buy (b-)” rating on shares of Xylem in a report on Monday, December 29th. Finally, Citigroup dropped their target price on shares of Xylem from $182.00 to $174.00 and set a “buy” rating for the company in a research report on Wednesday, February 11th. Nine analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $158.08.
View Our Latest Stock Analysis on Xylem
About Xylem
Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.
The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.
Recommended Stories
- Five stocks we like better than Xylem
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- What a Former CIA Agent Knows About the Coming Collapse
- Elon Musk already made me a “wealthy man”
- Unlocked: Elon Musk’s Next Big IPO
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.
